Decoding spliceosome inhibition: Isobaric tag-based proteomic profiling of pladienolide B treated human cell lines
Journal of Proteomics · 2026-01 · 323 · 105565
DOI: 10.1016/j.jprot.2025.105565 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteomics, 2026-01. Verfasst von Xcanda Ixchel Herrera Lopez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Harvard Medical School, Boston, MA 02115, United States. Hauptthemen laut MEDLINE: Proteomics, Spliceosomes, Epoxy Compounds, Macrolides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institutes of Health, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Pladienolide B (Pla-B) is a potent splicing modulator that has shown promise in cancer treatment, but its cellular effects remain incompletely understood. We investigated the dose-associated effect of Pla-B on human cell lines using isobaric tag-based quantitative proteomics and phosphoproteomics techniques. We quantified over 10,000 proteins and 19,000 phosphorylation events in SH-SY5Y cells, revealing dose-associated changes in protein abundance and phosphorylation status. Low Pla-B concentrations induced significant alterations in nuclear proteins, specifically those involved in transcription and cell division. Higher concentrations led to more extensive proteome remodeling, affecting chromatin-associated proteins and transcription. Phosphoproteome analysis uncovered alterations in the phosphorylation states of proteins including the splicing factor subunit SF3B, suggesting complex regulation of signaling pathways. Our findings reveal the detailed proteomic landscape of Pla-B's effects, offering insights into its role in the global proteome, which may guide future therapeutic applications and rational drug design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Harvard Medical School, Boston, MA 02115, United States.
- Department of Cell Biology, Harvard Medical School, Boston, MA 02115, United States. Electronic address: joao_paulo@hms.harvard.edu.
Förderung
- NIGMS NIH HHS
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Lopez, X. I. H., Martinez-Perez, K., Thakurta, S. G., Levi, B. P., & Paulo, J. A. (2026). Decoding spliceosome inhibition: Isobaric tag-based proteomic profiling of pladienolide B treated human cell lines. Journal of Proteomics, 323, 105565. https://doi.org/10.1016/j.jprot.2025.105565
Vancouver
Lopez XIH, Martinez-Perez K, Thakurta SG, Levi BP, Paulo JA. Decoding spliceosome inhibition: Isobaric tag-based proteomic profiling of pladienolide B treated human cell lines. Journal of Proteomics. 2026;323:105565. doi:10.1016/j.jprot.2025.105565
BibTeX
@article{Lopez2026,
author = {Lopez, Xcanda Ixchel Herrera and Martinez-Perez, Karina and Thakurta, Sanjukta Guha and Levi, Benjamin P and Paulo, Joao A},
title = {Decoding spliceosome inhibition: Isobaric tag-based proteomic profiling of pladienolide B treated human cell lines},
journal = {Journal of Proteomics},
year = {2026},
volume = {323},
pages = {105565},
doi = {10.1016/j.jprot.2025.105565}
}
EUVIMED